Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations

<p>Abstract</p> <p>Background</p> <p>Intravenous methylprednisolone (IV-MP) is an established treatment for multiple sclerosis (MS) relapses, accompanied by rapid, though transient reduction of gadolinium enhancing (Gd+) lesions on brain MRI. Intermittent IV-MP, alone o...

Full description

Bibliographic Details
Main Authors: Yassouridis Alexander, Holsboer Florian, Wismüller Axel, Blazevic Mirjana, Schwan Michaela, Held Ulrike, Schumann Erina, Kümpfel Tania, Then Bergh Florian, Uhr Manfred, Weber Frank, Daumer Martin, Trenkwalder Claudia, Auer Dorothee P
Format: Article
Language:English
Published: BMC 2006-05-01
Series:BMC Neurology
Online Access:http://www.biomedcentral.com/1471-2377/6/19

Similar Items

Similar Items